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a  b  s  t  r  a  c  t
The  ability  of  an  anion  exchange  membrane  to purify  a  -retrovirus  was  assessed  and  optimised  with
respect  to different  loading  and  wash  buffers.  Recoveries  of  infectious  virus  greater  than  50%  were  con-
sistently  obtained,  while  speciﬁc  titre  was  increased  up  to  one  thousand  fold  when  compared  to  the
material  loaded.  Speciﬁc  proteins  removed  and  retained  by  this  optimised  process  were  identiﬁed  by
mass spectrometry.  It was  possible  to  successfully  bind  and  elute  the  equivalent  of  1.27 × 108 Ifu/ml  ofeywords:
hromatography
ene therapy
irus
ion  exchange  membrane.  This  could  then  be  highly  concentrated,  with  infectious  virus concentrated  to
a maximum  of  420-fold  compared  to the  load.
©  2014  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/3.0/).embrane adsorption
etrovirus
. Introduction:
Retroviral gene therapy vectors are a promising class of gene
elivery vectors and have been used in recent successful and ongo-
ng clinical trials. They are advantageous in their ability to stably
ntegrate genetic information into a target cell, carry a relatively
arge genetic payload and have low immunogenicity [1]. Globally,
s of June 2013 there are 69 phase III clinical trials involving gene
herapy treatments of all types and 266 trials at all stages involving
etroviral vectors. These trials have a broad range of target dis-
ases, from hereditary conditions such as x-linked severe combined
mmunodeﬁciency (X-SCID) to cancer [2]. Retroviral vectors used
n gene therapy must be of high purity, high concentration and free
f replication competent virus. Current methods of production are
enerally limited in scalability; thus, there exists an urgent need for
he development of a production and puriﬁcation process that can
enerate batches of vector with high yield and of sufﬁcient qual-
ty for clinical use [3]. Concentration of a retroviral vector during
ownstream processing allows a reduction in the burden on pro-
esses downstream [4] and improvement in transduction efﬁciency
5].
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membranes and microcapillary ﬁlms have demonstrated their
ability to be used in virus puriﬁcation [6–9]. More speciﬁcally,
macroporous ion exchange membranes have demonstrated high
dynamic capacity for viruses and other large biomolecules such
as plasmid DNA [8,10]. This large dynamic capacity is attributed
to their large pores, which allow high rates of mass transfer of
large biomolecules to binding sites throughout the chromato-
graphic media relatively independent of residence time [11]. Ion
exchange membranes have high dynamic capacity for lentiviral
vectors and an ability to substantially concentrate them. Both the
Mustang® Q and LentiSELECT anion exchange membranes have
enabled successful concentration and puriﬁcation of lentiviral vec-
tors [8,9,12,13]. While no data on concentration factors achieved
were reported by Kutner et al. [8], it is estimated that using a
Mustang Q membrane with a volume of 0.18 ml they were able
to concentrate a lentiviral vector an estimated 140-fold. This is sig-
niﬁcantly higher than the concentration factors achieved with any
retrovirus by traditional chromatography, with a maximum con-
centration of between 1.5 and 5-fold being achieved by Rodrigues
et al. [14] using a packed bed column while other membrane
chromatography devices only achieved a maximum of 11-fold con-
centration [9], see Table 1.Mustang Q membrane is a polyethersulfone (PES)-based mem-
brane with a 0.8 micron nominal pore size and a surface coating of
an irreversibly cross-linked polymer containing pendant Q groups
[15].
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Table  1
shows selected methods of virus puriﬁcation and concentration and their ability to
concentrate retroviruses.
Device Virus Concentration
factor
Reference
Streptavidin Magnespheres® Lentivirus 2500 [18]
Mustang® 0.18 ml  Lentivirus ∼140 Estimate [8]
Fractogel® DEAE -Retrovirus 1.25–5 [14]
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LentiSELECT 500 -Retrovirus 11 [9]
These data indicate the utility of membrane chromatography for
entiviral vector puriﬁcation. However, there is limited information
vailable on the puriﬁcation of -retroviral vectors, a frequently
sed retroviral gene therapy vector [2,9]. With concentration of
iral gene therapy vectors being so important in their dosing
nd efﬁcacy choosing a puriﬁcation strategy that provides both a
igh concentration and satisfactory puriﬁcation is vital. This paper
xamines the utility of the Mustang Q membrane for puriﬁcation
nd concentration of retroviral vectors, with an emphasis on a -
etroviral vector based on a murine leukaemia virus (MLV).
. Materials and methods
.1. Chemicals
The following were purchased from Sigma-Aldrich (Poole, UK):
odium Hydroxide, Hydrochloric Acid, Sodium Chloride, Ammo-
ium Acetate, Ethanol, Bovine RNase, Trypan Blue, Bovine Serum
lbumin, Dithiothreitol (DTT), Tris–HCl, methanol, glycine, Tween-
0 and acetone. All chemicals used were Molecular Biology grade.
.2. Tissue culture reagents
Penicillin streptomycin solution, DMEM (Dulbecco’s Modi-
ed Eagles Medium), Phosphate Buffered Saline (PBS), polybrene
hexadimethrine bromide), l-glutamine and Trypsin were pur-
hased from Sigma-Aldrich (Poole, UK). RPMI (Rothwell Park
emorial Institute) and foetal calf serum (FCS) were purchased
rom Invitrogen (Paisley, UK). T75 and T175 tissue culture ﬂasks and
6 well culture plates were obtained from Fisher Scientiﬁc (Lough-
orough, UK) and Star Labs (Milton Keynes, UK). FACS tubes were
btained from Bio-Rad (Hertfordshire, UK).
.3. Cell lines
All cell lines were kindly supplied by Dr. David Darling of
ings College London. These include the EcoPack2 cell line for
FP carrying MLV  retroviral vector production (Clontech, Saint-
ermain-en-Laye, France) and the murine cell line 32Dp210 used
or retrovirus titration.
.4. Cell culture
All cell culture was performed at 37 ◦C with a 5% (v/v) CO2
nriched atmosphere, passaged at 80% conﬂuency and counted
sing a haemocytometer. All culture media contained 10% (v/v) FCS
nd 100 U/ml penicillin and 100 mg/ml  streptomycin.
.5. Production of ecotrophic MLV  retroviral vectorThe EcoPack2 cell line (Clonetech, France) was cultured in T175
issue culture ﬂasks seeded at 1 × 105 cell/ml until 80% conﬂuence
as achieved. At this point the supernatant was  harvested and
ither used immediately or aliquoted and frozen at −80 ◦C.gr. A 1340 (2014) 24–32 25
2.6. Puriﬁcation using the Mustang Q membrane
The Mustang Q membrane coin (0.35 ml  membrane volume)
and coin holder (Pall Europe, Portsmouth UK) were attached
to a Masterﬂex® L/S® peristaltic pump (Cole-Palmer, London
UK) equipped with a Masterﬂex® L/S® Easy-Load® pump head
(Cole-Palmer, London, UK). MLV  containing viral supernatant was
produced as described above. The viral supernatant was then clar-
iﬁed using a 0.45 m pore ﬁlter (Millipore, Elze, Germany) and
titrated to 25 mM Tris–HCl pH 7 ± 0.1 or pH 8 ± 0.1 as required,
using 1 M NaOH, with either no additional salt, 0.3 M NaCl, 0.6 M
NaCl or 0.8 M NaCl, pH was  determined using a sterile pH probe
(Applisens ltd, NL). The Mustang Q coin assembly was  sanitised
at a ﬂow rate of 3.5 ml/min using 10 ml  of 1 M NaOH followed by
10 ml  of 1 M NaCl and then conditioned using wash buffer contain-
ing the same NaCl concentration and at the same pH as the load
or 800 mM NaCl pH 8 ± 0.1.One hundred ﬁfty millilitres of titrated
supernatant was  then loaded onto the Q membrane. The Q mem-
brane was  then washed with 12 ml  of wash buffer and eluted using
3.6 ml  of 1.3 M NaCl, 25 mM Tris–HCl pH 8 ± 0.1. Fractions of 0.6 ml
were collected and analysed for viral titre using FACS and total pro-
tein as described above. One experiment was  performed using a
Mustang Q XT Acrodisc®, all volumes were altered to account for
the 0.85 ml  Q membrane volume. All experiments were performed
at room temperature, which was maintained between 18 and 21 ◦C.
2.7. Gradient elution experiments
150 ml of MLV  containing viral supernatant was loaded onto the
Mustang Q coin unit as described above. The MLV  was then eluted
using a step gradient from 0.9 M NaCl to 1.4 M NaCl 25 mM  Tris–HCl
pH 8 ± 0.1. Each step in the gradient consisted of 6 ml of elution
buffer and was collected in 1 ml  fractions, which were analysed for
infective viral titre using FACS.
2.8. Large scale experiments using the Mustang Q coin unit
The Q membrane and viral supernatant were prepared as
described above in larger volumes, up to 1000 ml.  These were
loaded onto the Q membrane at an initial ﬂow rate of 10 mem-
brane volumes a minute, during which the material that ﬂowed
through the Q membrane was  collected.
2.9. Establishing infective viral titre using ﬂow cytometry
This was performed using murine 32Dp210 cells plated in RPMI,
10% FCS, 1% P/S and polybrene at 4.4 g/ml as in [6]. A Becton Dick-
inson FACScan was  used to read the GFP ﬂuorescence. The linear
range of target cell GFP ﬂuorescence to infective titre is between
approximately 5 and 30%.
2.10. Total protein determination
Quantitative protein determination was carried out using a
standard Bradford assay, (Sigma, Dorset UK). It was performed
using 96 well plates in an EL340 plate reader from Bio Tek instru-
ments (Bedfordshire, UK).
2.11. SDS-PAGE and silver stain analysis of protein content
All SDS-PAGE gels used were Invitrogen (Paisley, UK) 15 or
10 well 4-to-12% bis tris precast Nu-PAGE mini gels and were
run according to the manufacturer’s instructions. Invitrogen’s
Mark12TM unstained standard was used as a molecular weight
marker at a 1 in 20 dilution. After running at 200 V for 35 min  the
gels were silver stained with the SilverSnap 2 stain kit from Pierce
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Northumberland, UK). Reduction of samples was performed with
TT. Gels were photographed on a MEDALight light panel (Morco,
K).
.12. Western blotting
A semi dry protocol was used, with the primary antibody being a
abbit polyclonal to MLV  GAG from Abcam (Cambridge, UK) diluted
 in 1500 in 5% skimmed milk powder (Marvel, Dublin, Ireland)
n PBST (PBS containing 0.1% Tween-20). The secondary was an
nti-rabbit IgG conjugated to HRP from GE Healthcare (Bucking-
amshire, UK) diluted 1 in 1000. After the SDS-PAGE was  run
ith Novex sharp pre-stained protein standards (Invitrogen, UK)
he protein was transferred to PVDF membrane (GE Healthcare,
uckinghamshire, UK) using a Transfer-Blot Semi-Dry Transfer Cell
Bio-Rad, Hertfordshire, UK) at 15 V for 1 h. The blot was developed
sing the ECL Prime kit from GE Healthcare (Buckinghamshire, UK).
isualisation and imaging was performed using a G:Box system
Syngene, Cambridge, UK).
.13. Preparation of samples for 2D-DiGE and mass spectrometry
Two dimensional difference gel electrophoresis (2D-DiGE) and
lectrospray ion trap mass spectrometry (ESI-Trap) followed by
earching of the NCIB protein database was performed by the
ambridge Centre for Proteomics (CCP). To prepare samples to
ndergo these processes insoluble material had to be removed.
herefore, the samples were puriﬁed using ammonium acetate and
cetone precipitation.
.14. Measurement of p30 protein concentration
The measurement of retroviral p30 concentration was  per-
ormed using the QuickTiterTM MuLV Core Antigen ELISA Kit (MuLV
30) (Cambridge Bioscience, Cambridge, UK) as directed. Each sam-
le was performed in duplicate and read using an EnVision 2104
ultilabel reader (PerkinElmer, Massachusetts, USA).
.15. Measurement of dsDNA concentration
dsDNA concentration was measured using the PicoGreen Assay
it from Invitrogen (Paisley, UK) according to the improved method
roposed by Charlton and colleagues [16] using a Perkin Elmer
S50B plate reader (Massachusetts, USA).
. Results and discussion
To establish the capacity of the Mustang Q membrane for an MLV
ased -retrovirus large volumes of MLV  containing supernatants
ere prepared and loaded onto Mustang Q membrane devices. The
upernatant that passed through the Q membrane was assayed for
nfective virus and viral capsid p30 protein content, where indi-
ated. The Q membranes were eluted and the fractions collected
ere titred for infectivity.
Fig. 1 demonstrates the high capacity for MLV  of the Mustang Q
embrane. It shows the ratio of infectious titre in the ﬂow through
elative to infectious titre in the feed at different time points during
he loading of 1000 ml  of MLV  supernatant onto a Mustang Q mem-
rane. It can also be seen that the infective titre in the ﬂow through
s either below, or on the limit of accurate quantiﬁcation. There is a
radual increase in infectivity towards the end of the load, suggest-
ng breakthrough is occurring. A summary of three experiments in
hich large volumes of supernatant were applied to the Mustang
 coin assembly is shown in Table 2. In all three experiments it can
e estimated that at least 70% of the loaded virus bound to the Q
embrane with between 45 and 56% being recovered in the eluate.gr. A 1340 (2014) 24–32
Macroporous adsorbers including the Mustang Q membrane have
been shown to be able to adsorb large entities such as viruses inde-
pendent of ﬂow rate [8,11,13]. Therefore increasing the residence
time of the load in the Mustang Q membrane would most likely
not lead to increased recovery. However, a reduction in the total
load below the 7.86 × 107 ± 3.36 × 105 Ifu used to produce Fig. 1
could increase recovery by reducing the amount of virus lost due
to breakthrough.
Despite detection of infectious virus ﬂowing through the mem-
brane, the lack of clear evidence for signiﬁcant breakthrough in
the ﬂow through fractions of these experiments demonstrates
that anion exchange membranes have a large capacity for -
retroviruses. The Q membrane was able to adsorb virus from a
feed equivalent to over 2857 membrane volumes. This large capac-
ity coupled with the high mass transfer rate of viruses within the
Mustang Q membrane resulted in a high concentration of infec-
tive virus upon elution. Table 2 shows that the recovered virus was
concentrated between 125 and 132-fold, with peak concentration
factors of 420-fold, which represented 60% of the total recovered
virus while 95% of the recovered virus was concentrated 221-fold.
This is clearly demonstrated in Fig. 2 where the difference in the
concentration of virus in the elution fractions can be seen, with
fraction 5 containing 60% of the recovered virus in 600 l.
To further investigate the capacity of the Mustang Q membrane
1775 ml  of MLV  containing supernatant was  loaded onto a Mus-
tang Q XT Acrodisc, a scale-down tool for the larger Mustang XT
units. Loading commenced at an initial ﬂow rate of 10 MV/min
(8.6 ml/min), which by the end of the load had fallen to ∼6 ml/min.
The fractions collected were analysed for both infective virus and
MLV  p30 capsid protein, the results of which can be seen in Fig. 3
and Table 3. As in the previous experiments some virus is detected
in the ﬂow through, but at a level too low to accurately quantify. As
can be seen in Fig. 3A and B and Table 3 the measured or estimated
viral titre at each section of the puriﬁcation run does not match the
viral protein concentration. The eluate contains 48.29 ± 7.18% of
the loaded virus yet only contains 22.47 ± 0.01% of the loaded p30
protein. This equates to 1.29 Ifu to every 1 ng of p30 in the load and
307 Ifu to every 1 ng of p30 in the eluate. Therefore, while the p30
protein content cannot help indicate infectious titre it does show
that viral protein not associated with infectious virus is removed
in the ﬂow through. Additionally, the mass balance only accounts
for 74% of the viral protein present in the feed and indicates that
there is viral protein bound to the membrane after elution, some-
thing previously observed by Grein et al. [17] during their study of
baculovirus puriﬁcation. On elution infectious virus was recovered
concentrated 179-fold, with 99% of recovery found in two fractions
concentrated 266-fold and the peak fraction, which contained 77%
of the recovered virus being concentrated 410-fold. This peak con-
centration factor is similar to that observed with the Mustang Q
coin.
The ability to provide large concentration factors whilst
simultaneously providing extensive puriﬁcation of a -retrovirus
compares favourably with previously published data. Table 1 shows
a selection of devices used for retrovirus concentration and the
results obtained. The concentration factors presented here are
almost double the highest estimated concentration factor achieved
for any retroviruses, using any type of chromatography device.
The previous maximum concentration factor achieved for a -
retrovirus using chromatography is 11 fold, here we demonstrate
concentration factors an order of magnitude higher [9]. The con-
centration factors achieved are also the highest recorded for this
type of retrovirus, as well as being over 40 times higher than those
reported with any packed bed chromatography device. Similar lev-
els of concentration have only been demonstrated previously using
ultraﬁltration or a scaled down version of the Mustang Q membrane
[8,9,14,18,19].
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Fig. 1. is a scatter graph showing the ratio of the measured infectious titre in the ﬂow through relative to the load during an experiment where 1000 ml  of murine leukaemia
virus  containing supernatant adjusted to 25 mM Tris–HCl pH 8 was loaded on to a 0.35 ml  Mustang Q coin unit at 10 Membrane volumes a minutes at an initial ﬂow
rate  of 3.5 ml/min with an average ﬂow rate of 2.9 ml/min over the experiment. The load contained 7.86 × 107 ± 3.36 × 105 Ifu. Dashed line represent the limit of accurate
quantiﬁcation of the assay ≥5% GFP positive target cells. Infectivity was  measured in triplicate.
Table 2
shows the total load, ﬂow through, recovery and concentration factor achieved when murine leukaemia based viral vectors are bound to and eluted from the Mustang Q coin
unit.
Load (Ifu) Load (ml) Flow through (%) Recovery (Ifu) recovery (%) Peak
concentration
factor (fold)
Total
concentration
factor (fold)
9.29 × 107 ± 5.25 × 106 800 29.1 ± 1.4 3.9 × 107 ± 5.99 × 106 44.8 ± 6.9 404 125
7.72  × 107 ± 2.01 × 105 790 <30 4.11 × 107 ± 5.65 × 106 56.7 ± 3.0 420 140
7.86  × 107 ± 3.36 × 106 1000 n/a 3.25 × 107 ± 2.74 × 106 44.1 ± 3.7 321 132
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3ig. 2. is a bar graph showing the titre, protein content and dsDNA content measure
ontaining cell culture supernatant titrated to 25 mM Tris–HCl pH 8 onto a Mustan
In order to establish the maximum attainable purity of -
etrovirus puriﬁed using this Q membrane chromatography device,
uffer conditions and its elution proﬁle were analysed. It has been
reviously established that the application of 0.8 M NaCl pH 8 to the
ustang Q membrane eluted a majority of protein impurities and
able 3
hows the total load, ﬂow through, recovery and concentration factor achieved when 1
00  mM NaCl 25 mM Tris–HCl pH 7 is bound to and eluted from the Mustang Q XT Acrod
Load Load concentration Flow through 
Infectious
virus
2.39 × 108 ± 3.77 × 105 Ifu 1.26 × 105 ± 8.68 × 103 Ifu n/a 
p30  Protein 1.04 × 105 ± 15.5 ng 64.46 ± 0.38 ng/ml 5.32 × 104 ± 11.1 lution fractions collected following the loading of 790 ml of murine leukaemia virus
in unit. Each fraction is of 0.6 ml.   is dsDNA,  is Ifu  is protein.
dsDNA, while not eluting signiﬁcant quantities of infective virus
(data not shown). To identify where MLV  elutes from the Mus-
tang Q membrane step gradients between 0.8 M NaCl and 1.5 M
NaCl were applied to the membrane utilising steps of 100 mM.
Fig. 4 shows that infectious virus was found in multiple fractions
775 ml  of murine leukaemia based viral vector containing supernatant titrated to
isc.
Recovery Recovery
(%)
Peak
concentration
factor
Total
concentration
factor
1.08 × 108 ± 1.61 × 107 Ifu 48.29 ± 7.18 410 179
ng 2.34 × 104 ± 24.4 ng 22.47 ± 0.01 n/a 30
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Fig. 3. (A) is a bar graph showing the percentage of total loaded infectious virus detected in different fractions of an experiment where 1775 ml of murine leukaemia virus
(MLV)  containing supernatant adjusted to 300 mM NaCl 25 mM Tris–HCl pH 7 was  loaded on to a Mustang Q XT Acrodisc at an initial ﬂow rate of 10 membrane volumes a
minutes, equal to 8.6 ml/min, with an average ﬂow rate of 6.45 ml/min. The load contained 2.39 × 108 ± 3.77 × 105 Ifu. Flow through (FL) fractions 1–4 represents the ﬁrst
650  ml  of the ﬂow through. FL 5–7 represents the subsequent 600 ml and FL 8–18 represents the ﬁnal 525 ml.  The titre in these fractions is an estimate as although infectivity
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 and ‘Elution’ represents elution from the membrane using 12 ml  1.3 M NaCl 25 m
rotein  detected in different fractions, measured using a sandwich ELISA in duplica
t multiple concentrations of NaCl with up to four peaks of elution,
anging from 0.9 M to 1.3 M NaCl, with most of the virus eluting
ith the application of 1.1 or 1.2 M NaCl 25 mM  Tris–HCl pH 8. The
ccurrence of multiple peaks of elution of infective virus from chro-
atography matrices has been previously reported; the elution of a
entivirus from a packed bed anion exchange column produced two
eaks, which were found to have differing transduction efﬁciencies
20] and two elution peaks can also be identiﬁed from the work
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ig. 4. (A) is a bar graph showing the infectious titre of fractions collected during step grad
f  150 ml  of viral supernatant containing 1.71 × 107 ± 3.97 × 105 Ifu, titrated to 0.3 M Na
00  mM steps. All fractions were 1 ml  and all eluants were buffered with 25 mM Tris–H
nfectivity was measured in triplicate. target cells. ‘Wash’ represents a 20 ml wash with 300 mM NaCl 25 mM Tris–HCl pH
–HCl pH 8. (B) is a bar graph showing the percentage of total loaded MLV  core p30
published by Kuiper et al. on the use of CHT for virus puriﬁcation
[19].
To examine the effect of the loading conditions on -retrovirus
puriﬁcation, MLV  supernatant containing no salt apart from that
contained within cell culture media (i.e. approximately 103 mM
NaCl), or with additional salt to a concentration of 300, 600, or
800 mM were adjusted to pH 7 ± 0.1 or 8 ± 0.1 using 1 M NaOH and
loaded onto a Mustang Q membrane. The membranes were washed
1.31.31.31.31.21.21.21.21.21.21.11.11.11.11.1
NaCl in Eluant (M)
ient elution of murine leukaemia virus from a Mustang Q membrane. Load consists
Cl 25 mM Tris–HCl pH 8. Gradient elution was from 0.9 M NaCl to 1.5 M NaCl in
Cl. Where no number is reported the viral titre is below the limit of quantitation.
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Fig. 5. (A) is a bar graph showing the total recovery of infectious virus after binding and elution from Mustang Q membranes of 150 ml  samples of murine leukaemia virus
containing supernatant adjusted to different NaCl concentrations and pHs. All experiments n = 2 except, 103 mM pH 8 NaCl n = 11 and 300 mM NaCl pH 8 n = 3. (B) is a bar
graph  that shows the total protein concentration in the infectious virus containing fraction of the eluate of the same experiments, n = 2. (C) shows an image of a silver
stained SDS-PAGE analysis of infective virus containing elution fractions from one replicate of the above mentioned experiments. (D) shows an image of a western blot of an
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PDS-PAGE analysis of infective virus containing elution fractions of the above ment
t  pH 7 and  indicates experiments performed at pH 8.
nd then eluted using 1.3 M NaCl 25 mM Tris–HCl pH 8. Fractions
ere collected during each step and were assayed for infectious
irus and protein content. The total recovery and purity of the elu-
te from each loading condition was then compared and presented
n Fig. 5.
Fig. 5 shows that as the concentration of salt in the load is
ncreased so does the purity of the eluate. The total protein con-
ent of the virus containing eluate fractions is greatly reduced with
n increase in NaCl concentration and pH, see Fig. 5B. With no addi-
ional salt in the load and titration to pH 7 total protein in the
luate was 3592 ± 169 g, whilst with 800 mM NaCl in the load
t was reduced to 57 ± 55 g. The reduction in total protein was
ven greater at pH 8, with protein concentration in the eluate of
968 ± 801 g and 60 ± 38 g for a load containing no added NaCl
nd 800 mM NaCl, respectively. This is over a 100-fold decrease in
otal protein content compared to the protein content of the load.
Loads titrated to pH 8 provided consistently lower total protein
n the eluate when loading at salt concentration below 800 mM
ompared to pH 7. The increase in purity with increasing loading
uffer NaCl concentration or pH is further supported by SDS-
AGE analysis, as shown in Fig. 5C. A range of both high and lowexperiments probed with anti-p30 antibodies.  indicates experiments performed
molecular weight protein species present in the eluates can be iden-
tiﬁed. Bands potentially representative of viral capsid protein p30
and matrix protein p15 are present at approximately 30 kDa and
15 kDa. The presence of p30 is conﬁrmed by western blot analy-
sis of the same samples, with strong anti-p30 antibody staining at
30 kDa, see Fig. 5D. This p30 is present as a result of eluted viral
particles and potentially as free protein present in the cell culture
supernatant.
The presence of fewer and lighter bands in the SDS-PAGE analy-
sis of the eluate fractions processed at higher NaCl concentrations
and pH is indicative of the removal of impurities. This increase in
purity can be demonstrated in the SDS-PAGE analysis by the pres-
ence of a prominent band at around 35 kDa using a load condition of
600 mM NaCl 25 mM Tris–HCl pH 7 and its complete absence using
the same conditions at pH 8. The increase in purity with increased
concentrations of NaCl can most likely be attributed to increased
competition between chloride ions and other anionic species in the
load for ion exchange sites on the membrane. This increase in com-
petition for binding will cause impurities with lower afﬁnity for the
ion exchange sites to ﬂow through the membrane, with this effect
increasing with the concentration of NaCl.
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Fig. 6. is a bar graph showing the protein concentration and infectious titre of fractions collected during washing and elution of MLV  from a Mustang® Q membrane. The
load  consists of 150 ml  of viral supernatant containing 1.33 × 107 ± 8.2 × 104 Ifu, titrated to 0.3 M NaCl 25 mM Tris–HCl pH 8. Washing was performed ﬁrst with 0.3 M NaCl
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he  limit of detection.  indicates protein concentration and  indicates Ifu.
Despite the increase in purity achieved with alteration of the
oading buffers, the increase in salt concentration above 600 mM
roduces an eluate with a reduced average total recovery of infec-
ious virus; this seems especially marked at pH 8. Total recovery
f virus varies from between 62.5 ± 24.8% using a load titrated
o 300 mM NaCl pH 7 and 20.8 ± 7.8% using a load titrated to
00 mM NaCl. The reduction in recovery with an increase in salt
oncentration could be caused by many factors, irreversible bind-
ng, instability of retrovirus in high salt, or potentially reduced
inding in high salt. Low stability of retrovirus in high salt con-
entration has been previously reported and is therefore a likely
actor in loss of infective titre [9,21].
The lower total protein eluted from experiments run with
oading buffers at pH 8 is potentially caused by impurities bind-
ng irreversibly to the membrane. As mentioned above, such
rreversible binding has been observed by Grein and colleagues [17]
hen assessing different membrane chromatography systems for
aculovirus puriﬁcation.
To examine whether similar ﬁnal purities to those produced
ith a high salt load could be achieved using wash buffers of a
imilarly high salt concentration, experiments utilising 800 mM
aCl washes were performed. Fig. 6 and Table 4 show that
ddition of an 800 mM NaCl 25 mM Tris–HCl pH 8 wash step
nto the chromatographic process greatly increases the purity
f the eluted virus relative to runs without the high salt wash
tep. Log removal values of 3.51 and 2.21 are achieved for
rotein and dsDNA, respectively, when using the extra wash
tep, which are approximately 1 LRV higher than without it.
owever, the total protein in the virus containing fractions is
igher than that achieved using pH 8 loads containing 600 and
able 4
hows the results of puriﬁcation runs of murine leukaemia virus using a Mustang® Q ani
No added salt in load 300 mM NaC
Recovery (%) 48.5 ± 23.9 (n = 11) 49.3 ± 30.3
Total  dsDNA in load (mg) 13.3 ± 6.88 9.5 ± 0
Total  dsDNA in eluate post RNase (mg) 0.378 ± 0.005 0.146 ± 0
LRV  for DNA 1.55 1.81
Total  protein in eluate (g) 2968.4 ± 801.6 445.9 ±
LRV  for protein 2.18 ± 0.20 2.60 ± 0
Average increase in speciﬁc titre (fold) 104 ± 48 557 ±were buffered with 25 mM Tris–HCl pH 8. Where no titre is reported titre is below
800 mM NaCl or pH 7 800 mM NaCl. The differences in loads,
caused by differential dilution to achieve the required load NaCl
concentration, could be a factor in the difference between the elu-
ate total protein concentrations of the experiments involving an
800 mM NaCl wash step and 800 mM NaCl concentration in the
load. However, the high purities achieved using this additional
wash step were also complemented by the relatively high recover-
ies of 45.3 ± 2.9% and 51.8 ± 5.9% compared to loading in 800 mM
NaCl.
The difference in recovery recorded between the high salt load-
ing buffers and the high salt wash buffers indicates that there is a
potential detrimental effect on viral infectivity, binding or elution
from the membrane that occurs due to loading in high salt. Here,
the majority of infectious virus is only recovered from the mem-
brane at salt concentrations above 800 mM NaCl which suggests
that the loss of recovery is most likely due to loss of infectivity
during application.
The results of these experiments are supported by the data of
Rodrigues et al. [22], who found that the optimum wash and elu-
tion conditions for a -retroviral vector from quaternary amine
ion exchange matrices was 864 and 1338 mM NaCl, respectively,
buffered with 20 mM phosphate buffer pH 7.5. Using these condi-
tions they were able to provide 1 log of DNA removal and between
2 and 3 logs of removal for protein impurities, results which are
matched here with samples 10-fold larger. It is only by using
afﬁnity methods such as heparin IMAC that chromatographic meth-
ods have produced retroviral vectors of similar purity [6,23,24].
These methods often require chemical or biological modiﬁcation
of the target molecule [25,26], making them unattractive for clin-
ical products. Traditional packed bed chromatographic methods
on exchange membrane utilising different buffer conditions.
l in load 0.8 M Wash 1 0.8 M Wash 2 0.8 M Wash combined
 (n = 3) 45.3 ± 2.9 51.8 ± 5.9 48.5 ± 8.0
.06 n/a 10.01 ± 0.01 n/a
.005 0.029 ± 0.004 0.060 ± 0.004 0.045 ± 0.022
 n/a 2.21 n/a
 42.6 160.3 ± 9.8 88.0 ± 44.8 124.2 ± 68.6
.55 3.34 3.68 3.51 ± 0.24
 34 1257 1122 1189 ± 95
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Table  5
shows a summary of the proteins identiﬁed by electrospray mass spectrometry after
2D-DiGE of Pre and Post Chromatography MLV  samples.
Protein number Found in Identiﬁed as
1 Feed BSA
2  Eluate p30 Capsid protein
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[11] R. Ghosh, J. Chromatogr. A. 952 (2002) 13.3  Feed and eluate alpha-2-HS-glycoprotein ‘Fetuin’
4  Feed and eluate HSP 90
uffer from lower ﬂow rates and therefore increased process time
elative to a membrane chromatographic device processing an
quivalent volume [22]. While methods such as ultraﬁltration
ave been shown to provide equivalent levels of concentration to
hose presented here, with Kuiper et al. [19] concentrating a -
etroviral vector 160 fold using a 100 KDa membrane. However,
he level of reduction in impurities such as DNA and protein was
inimal.
A further experiment involving a high salt wash step was per-
ormed. The resulting eluate was compared to the original MLV
ontaining supernatant using two dimensional differential gel elec-
rophoresis (2D-DiGE). 2D-DiGE allowed the two samples’ protein
ngerprint to be compared simultaneously via the pre-staining of
ach sample with ﬂuorescent dyes. Comparing the pre and post
hromatography samples using this method makes it possible to
lucidate which protein impurities have had their concentration
educed. Four proteins chosen from the 2D-DiGE were further ana-
ysed via mass spectrometry. Of these; one protein was  detected
nly in the feed, Protein 1; one was only detected in the eluate,
rotein 2; and two which were detected in both feed and eluate,
rotein 3 and 4. A summary of this information can be seen in
able 5.
As shown in Table 5 protein 1 was identiﬁed as bovine serum
lbumin (BSA) and found only in the feed. BSA being present only
n the feed demonstrates the removal of protein impurities and
ighlights the increase in purity produced on elution. Protein 2
dentiﬁed as the retroviral Capsid protein p30 was  detected only
n the eluate and once again demonstrates the high concentration
actors produced on elution from the Mustang Q membrane. As this
rotein is too dilute to be detected in the feed but is detected in the
luate sample. Proteins 3 and 4 appear in both the feed and elu-
te. Therefore, they potentially represent proteins present in the
irus, both viral and host cell derived, as well as anionic impurities
resent in the cell culture media. Protein 3 was determined to be
etuin, a protein abundant in foetal serum [27]. Therefore, this pro-
ein impurity is most likely introduced by the foetal calf serum used
s a media additive. Fetuin is present in both load and elution frac-
ion and therefore appears to have a high afﬁnity for the Mustang
 membrane. In order to reduce or remove the burden this pro-
ein places on puriﬁcation, the use of adult sera or the reduction or
emoval of bovine serum in the cell culture media could be advan-
ageous in providing an eluate with a lower quantity of impurities.
rotein 4 was also found in both the load and the eluate and was
dentiﬁed to be heat shock protein 90 (HSP90), although due to the
volutionary conservation of the sequence the peptides mapped
dentically onto both bovine and human heat shock proteins. Heat
hock proteins have previously been found in virus preparations
28–30]. HSP90 is a cytosolic protein used both as a chaperone and
or internal signal transduction. Therefore, it is potentially present
n the cell culture supernatant and therefore virus preparations due
o cell lysis [31]. By reducing the stress on the cells during culture
nd preventing cell lysis the quantity of this protein released into
he supernatant could be reduced. However, it has also recently
een established that HSP90 can be found in preparations of both
espiratory syncytial virus and HIV-1. In respiratory syncytial virus
eat shock proteins have been determined to be important for virus
[
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particle formation and maturation [29] while in HIV-1 heat shock
proteins have been implicated in viral replication [28]. Therefore,
potentially the HSP90 may  not be an impurity but a protein involved
in virus production.
4. Conclusions
Anion exchange membranes have been shown to produce high
concentrations of retroviral vector upon elution, up to twice that
produced by any chromatography device and over 40 times higher
than packed bed devices. Adjusting the concentration of salt or pH
in the loading and wash buffers makes it possible to produce an
eluate of high purity. The use of a high salt wash buffer provides
for greater recovery than the use of a loading buffer of equiva-
lent salt concentration, whilst producing similar levels of impurity
removal, thus indicating a time dependant inactivation of virus in
the presence of high concentrations of NaCl. Using this system of
binding the -retrovirus to the Mustang Q membrane followed by
a high salt wash allowed for LRVs of 3.51 for protein and 2.21 for
DNA. The primary protein impurity removed by this wash step
was identiﬁed by mass spectrometry as being BSA. It was also
established that some proteins such as Fetuin and HSP90 were co-
puriﬁed with viral proteins and therefore alternative methods of
removal are required for them, potentially by reducing or remov-
ing them from cell culture media. Additionally, it was determined
that the Mustang Q membrane was  able to adsorb very large loads
of viral supernatant, equivalent to 2857-fold larger than the Q
membrane volume. The capacity of the Mustang Q membrane for
-retroviruses was also determined as at least 1.27 × 108 Ifu/ml
of membrane, the ﬁrst report of a chromatographic membrane’s
capacity for a -retrovirus.
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